Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $97.81 USD
Change Today -0.83 / -0.84%
Volume 545.6K
As of 10:43 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin J. Buehler

AgeTotal Calculated CompensationThis person is connected to 21 board members in 3 different organizations across 6 different industries.

See Board Relationships
57$6,141,620
As of Fiscal Year 2014

Background*

Mr. Kevin J. Buehler served as the President of Alcon Laboratories, Inc., a division of Novartis from April 2011 to May 1, 2014. Mr. Buehler served as the Chief Executive Officer and President of Alcon, Inc., a division of Novartis from April 1, 2009 to 2011. He served as Chief Executive Officer of Alcon Laboratories, Inc. He served as the Chief Marketing Officer of Alcon Laboratories Inc., from February 2006 to April 2009, Senior Vice President of Global Markets from ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

2009-Present
Director
2015-Present
Director

Education*

BS
Carroll University, Inc.
BSBA
Carroll University, Inc.

Other Affiliations*

Annual Compensation*

Salary$382,691
Bonus$460,784
Total Annual Compensation$843,475

Stock Options*

Long Term Incentive Plan$1,075,234
All Other Compensation$4,222,911

Total Compensation*

Total Annual Cash Compensation$5,066,386
Total Short Term Compensation$843,475
Other Long Term Compensation$4,222,911
Total Calculated Compensation$6,141,620
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVS:US $97.81 USD -0.83

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
SFr.5.7M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-SPONSORED ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.